Xiaobing Chen
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- Mitochondrial Function and Pathology
- RNA Research and Splicing
- Extracellular vesicles in disease
Papers in
-
- RNA modifications and cancer 5
- RNA Research and Splicing 3
- Circular RNAs in diseases 3
- Extracellular vesicles in disease 3
- RNA Interference and Gene Delivery 2
-
- Cancer-related molecular mechanisms research 11
- MicroRNA in disease regulation 3
- Co-authors
- Bin Cheng (4 shared papers)Juan Xia (5 shared papers)Lin Ren (1 shared paper)Jiayan Li (1 shared paper)Xiaodan Chen (1 shared paper)Beibei Chen (11 shared papers)Tong Wu (3 shared papers)Xianyue Ren (2 shared papers)
- Journals
- Acta Pharmaceutica Sinica B (2 papers)Journal of Oral Pathology and Medicine (2 papers)Acta Biochimica et Biophysica Sinica (2 papers)Frontiers in Oncology (2 papers)Cancer Letters (1 paper)
- Partner nations
- ChinaUnited StatesRussia
In The Last Decade
Xiaobing Chen
39 papers receiving 843 citations
Peers
Comparison fields: 5 of 87
- Cancer Research 311
- Molecular Biology 490
- Molecular Medicine 22
- Oncology 88
- Immunology 67
Countries citing papers authored by Xiaobing Chen
This map shows the geographic impact of Xiaobing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobing Chen more than expected).
Fields of papers citing papers by Xiaobing Chen
This network shows the impact of papers produced by Xiaobing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobing Chen. The network helps show where Xiaobing Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobing Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 110 | |
| 2 | 2018 | 97 | |
| 3 | 2021 | 77 | |
| 4 | 2020 | 57 | |
| 5 | Association of long non-coding RNA HOTTIP with progression and prognosis in colorectal cancer. | 2015 | 54 |
| 6 | 2013 | 38 | |
| 7 | 2020 | 36 | |
| 8 | 2013 | 35 | |
| 9 | 2015 | 34 | |
| 10 | miR-489 acts as a tumor suppressor in human gastric cancer by targeting PROX1. | 2016 | 34 |
| 11 | 2022 | 27 | |
| 12 | 2011 | 26 | |
| 13 | 2023 | 24 | |
| 14 | 2014 | 23 | |
| 15 | 2022 | 16 | |
| 16 | 2021 | 14 | |
| 17 | 2016 | 14 | |
| 18 | 2022 | 13 | |
| 19 | 2013 | 13 | |
| 20 | 2016 | 10 |
About Xiaobing Chen
Xiaobing Chen is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 44 papers that have together received 848 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (5 papers), Immune cells in cancer (3 papers), RNA Research and Splicing (3 papers), Circular RNAs in diseases (3 papers), Extracellular vesicles in disease (3 papers), MicroRNA in disease regulation (3 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Cancer Research (311 citations), Molecular Biology (490 citations), Molecular Medicine (22 citations), Oncology (88 citations) and Immunology (67 citations). Xiaobing Chen has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Bin Cheng, Juan Xia, Lin Ren, Jiayan Li, Xiaodan Chen, Beibei Chen, Tong Wu, Xianyue Ren, Qinchao Hu and Yuzhou Zhao. Their work appears in journals such as Acta Pharmaceutica Sinica B, Journal of Oral Pathology and Medicine, Acta Biochimica et Biophysica Sinica, Frontiers in Oncology and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.